In addition, SETD2 is mutated in other cancer types, such as non‐small cell lung cancer, where VHL and PBRM1 mutations rarely occur, although this does not preclude the possibility that SETD2 cooperates with other mutated genes such as K‐RAS in context of lung cancer. This evidence concerns the gene KRAS and cancer.